Publication:
Silencing of microRNA-106b-5p prevents doxorubicin-mediated cardiotoxicity through modulation of the PR55α/YY1/sST2 signaling axis

Thumbnail Image
Files
Silencing of microRNA-106b-5p prevents doxorubicin-mediated cardiotoxicity through modulation of the PR55aYY1sST2 signaling axis.pdf(3.36 MB)
Datos suplementarios.pdf(4.92 MB)
Date
2023-05
relationships.isAuthorOfPublication
Profile Picture
Person
relationships.isSecondaryAuthorOf
relationships.isDirectorOf
Authors
Lax Pérez, Antonio Manuel ; Fernandez del Palacio, Maria Josefa ; Pascual Oliver, Silvia ; Ruiz Ballester, Miriam ; Fuster, Jose J ; Pascual Figal, Domingo A. ; Asensio Lopez, Maria del Carmen ; Soler Pardo, Fernando
item.page.secondaryauthor
item.page.director
Publisher
publication.page.editor
publication.page.department
Medicina
DOI
10.1016/j.omtn.2023.04.031.
item.page.type
info:eu-repo/semantics/article
Description
©2023. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ This document is the Accepted version of a Published Work that appeared in final form in Molecular Therapy - Nucleic Acids. To access the final edited and published work see https://doi.org/10.1016/j.omtn.2023.04.031
Abstract
publication.page.subject
Citation
Mol Ther Nucleic Acids. 2023 May 3:32:704-720. doi: 10.1016/j.omtn.2023.04.031. eCollection 2023 Jun 13.
URI
http://hdl.handle.net/10201/137581
item.page.embargo
Collections
Artículos
Ir a Estadísticas